Short Course Radiotherapy (NCT07147179) | Clinical Trial Compass
RecruitingNot Applicable
Short Course Radiotherapy
United States15 participantsStarted 2026-04-02
Plain-language summary
This is a single arm prospective pilot trial determining the safety of short-course radiation therapy in pediatric patients with incurable central nervous system malignancies.
Who can participate
Age range21 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male or female, aged 21 years or below
* Lansky performance status \>= 40
* Has a diagnosis of an incurable malignancy that:
* Originates outside the brain but is metastatic to 1 or more sites within the brain, or originates and recurs within the brain. For this diagnosis to be confirmed, there must be multidisciplinary review of up to date imaging at a pediatric tumor board with unanimous consensus of intracranial relapse or metastasis. If the consensus is not unanimous, short-interval repeat imaging with subsequent unanimous consensus would be required in order for this eligibility criteria to be met
* Has at least 1 targetable intracranial lesion as seen on imaging
* Has a multidisciplinary consensus recommendation for palliative intent radiation
* Consents to the study or has caregiver who is able to provide signed and dated informed consent. For subjects under the age of 18, a signed and dated assent form as able.
* Patients who had prior radiation in planned treatment area are also eligible to enter the trial
* Stated willingness to comply with all study procedures and availability for the duration of the study
Exclusion Criteria:
* Radiotherapy for curative intent
* Serious uncontrolled systemic or psychiatric disorders that would interfere with participation in the protocol
* Being planned for proton radiation